Brainsway Ltd.
BWAY · XNASCIK 1505065fmd_1ZCJCHYTSSV6XJMF5EMT70WRTYManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2017 to Dec 31, 2025, 13 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 11 | 16 | 23 | 22 | 30 | 27 | 32 | 41 |
| Cost of revenue | 3 | 4 | 5 | 5 | 7 | 7 | 8 | 10 |
| Gross profit | 9 | 13 | 18 | 17 | 23 | 20 | 23 | 31 |
| Research and development | 5 | 6 | 8 | 6 | 6 | 8 | 7 | 7 |
| Selling, general and administrative | 10 | 12 | 19 | 16 | 22 | 25 | 22 | 22 |
| Operating income | (7) | (5) | (8) | (5) | (5) | (13) | (5) | 1 |
| Interest expense | 0 | 1 | 1 | 0 | (2) | 1 | 1 | 2 |
| Income before taxes | (7) | (6) | (10) | (5) | (6) | (13) | (4) | 3 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net income from continuing operations | (7) | (6) | (10) | (5) | (6) | (13) | (4) | 3 |
| Net income | (7) | (6) | (10) | (5) | (6) | (13) | (4) | 3 |